Cargando…
Encephalopathy caused by lanthanum carbonate
Lanthanum carbonate is a nonaluminum, noncalcium phosphate-binding agent, which is widely used in patients with end-stage chronic kidney disease. Until now, no significant side-effects have been described for the clinical use of lanthanum carbonate, and there are no available clinical data regarding...
Autores principales: | Fraile, Pilar, Cacharro, Luis Maria, Garcia-Cosmes, Pedro, Rosado, Consolacion, Tabernero, Jose Matias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421591/ https://www.ncbi.nlm.nih.gov/pubmed/25984155 http://dx.doi.org/10.1093/ndtplus/sfr003 |
Ejemplares similares
-
C1q nephropathy in a patient with Gitelman syndrome
por: Rosado Rubio, Consolación, et al.
Publicado: (2011) -
Efficacy of crushed lanthanum carbonate for hyperphosphatemia in hemodialysis patients undergoing tube feeding
por: Kitajima, Yukie, et al.
Publicado: (2011) -
Angiosarcoma in vascular access after transplantation
por: Lucas Álvarez, Cristina, et al.
Publicado: (2013) -
Encephalopathy in a dialysis patient treated with lanthanum carbonate (LC)
por: Brancaccio, Diego, et al.
Publicado: (2012) -
Tuberous Sclerosis Associated with Polycystic Kidney Disease: Effects of Rapamycin after Renal Transplantation
por: Rosado, C., et al.
Publicado: (2013)